How the pandemic has taken an unspoken toll on N.J.’s transgender residents
Updated Mar 11, 2021;
Posted Feb 27, 2021
The extent to which the coronavirus pandemic has impacted members of the LGBTQ+ community in New Jersey remains widely unknown.
Facebook Share
Editor’s Note: A list of resources can be found at the end of this article.
A 23-year-old New Jersey native has been mostly unemployed for over a year. From late last year into early this year, she bounced between parts of New York and New Jersey in search of various sources of food and shelter.
She’s spent some nights on the streets, her stomach roaring at her louder than the winds whipping her left and right.
Reply
James K. Aikins, Jr., MD, FACOG, FACS
New Brunswick, February 4, 2021 – Expanding its team of highly specialized professionals in the treatment of routine, rare and complex cancers of the female reproductive system, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital (RWJUH), a RWJBarnabas Health facility, have named James K. Aikins, Jr., MD, FACOG, FACS chief of gynecologic oncology at Rutgers Cancer Institute and chief of gynecologic oncology services at RWJUH, New Jersey s largest academic medical center. He will also serve as Program Director for the Gynecologic Oncology Fellowship Program at Rutgers Robert Wood Johnson Medical School.
Share this article
Share this article
HOUSTON, Dec. 30, 2020 /PRNewswire/ Soliton, Inc., (Nasdaq: SOLY) ( Soliton or the Company ), a medical device company with a novel and proprietary platform technology, today announced the appointment of Sean J. Shapiro as Vice President of Sales, effective January 1, 2021.
Brad Hauser, Soliton s President and CEO, commented, We are very excited to have Sean join our team during this pivotal time for the company as we anticipate clearance of our 510(k) application for cellulite reduction during the first quarter of 2021. Sean is a seasoned sales executive who has successfully launched several aesthetic devices in the industry, and we look forward to leveraging his extensive experience as we prepare for the commercial launch of our RAP technology during the first half of next year.